All of the following appear to decrease hot flushes in menopausal women except:
**Core Concept**
Menopausal hot flushes are a complex phenomenon involving the interplay of various neurotransmitters, hormones, and thermoregulatory mechanisms. The hypothalamus plays a crucial role in detecting changes in blood temperature and initiating vasodilation to dissipate heat. Estrogen deficiency during menopause disrupts this delicate balance, leading to hot flushes.
**Why the Correct Answer is Right**
Hot flushes are thought to be mediated by the serotonin pathway in the hypothalamus. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) can decrease hot flushes by increasing serotonin levels, thereby modulating the thermoregulatory response. This is in contrast to non-selective serotonin receptor agonists, which may exacerbate hot flushes.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because SSRIs and SNRIs, such as fluoxetine and venlafaxine, have been shown to decrease hot flushes in menopausal women.
**Option B:** This option is incorrect because estrogen replacement therapy (ERT) is actually used to alleviate hot flushes in menopausal women, not decrease them.
**Option C:** This option is incorrect because clonidine, an alpha-2 adrenergic agonist, can decrease hot flushes by modulating the sympathetic nervous system.
**Clinical Pearl / High-Yield Fact**
Hot flushes are a common symptom of menopause, affecting up to 80% of women. Treatment options include lifestyle modifications, hormone therapy, and pharmacological interventions like SSRIs and SNRIs.
**Correct Answer: B. Estrogen replacement therapy (ERT)**